Atlas Trials

Suzhou BlueHorse Therapeutics Co., Ltd.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Suzhou BlueHorse Therapeutics Co., Ltd.

RecordFirmDate
A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer (NCT07444437)Suzhou BlueHorse Therapeutics Co., Ltd.2026-02-26
A Phase II Trial of LM103 in Advanced Melanoma (NCT07310784)Suzhou BlueHorse Therapeutics Co., Ltd.2025-12-16
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours (NCT06695689)Suzhou BlueHorse Therapeutics Co., Ltd.2024-10-17
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours (NCT06697665)Suzhou BlueHorse Therapeutics Co., Ltd.2024-01-23
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors (NCT05971589)Suzhou BlueHorse Therapeutics Co., Ltd.2023-08-01
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors (NCT05971576)Suzhou BlueHorse Therapeutics Co., Ltd.2023-08-01
A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors (NCT05941936)Suzhou BlueHorse Therapeutics Co., Ltd.2023-05-19
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors (NCT05366478)Suzhou BlueHorse Therapeutics Co., Ltd.2022-05-30

Track Suzhou BlueHorse Therapeutics Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.